Algert Global LLC Harmony Biosciences Holdings, Inc. Transaction History

Algert Global LLC

  • $4.25 Billion
  • Q4 2024

A detailed history of Algert Global LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Algert Global LLC holds 230,908 shares of HRMY stock, worth $8.54 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
230,908
Previous 90,941 153.91%
Holding current value
$8.54 Million
Previous $3.64 Million 118.42%
% of portfolio
0.19%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$31.86 - $41.49 $4.46 Million - $5.81 Million
139,967 Added 153.91%
230,908 $7.95 Million
Q3 2024

Nov 12, 2024
SELL
$30.0 - $39.95 $350,100 - $466,216
-11,670 Reduced 11.37%
90,941 $3.64 Million
Q2 2024

Aug 14, 2024
SELL
$28.81 - $33.01 $720,250 - $825,250
-25,000 Reduced 19.59%
102,611 $3.1 Million
Q1 2024

May 14, 2024
SELL
$29.93 - $35.06 $973,622 - $1.14 Million
-32,530 Reduced 20.31%
127,611 $4.29 Million
Q4 2023

Feb 14, 2024
BUY
$19.2 - $33.78 $2.39 Million - $4.2 Million
124,456 Added 348.76%
160,141 $5.17 Million
Q3 2023

Nov 13, 2023
SELL
$31.89 - $39.03 $150,839 - $184,611
-4,730 Reduced 11.7%
35,685 $1.17 Million
Q2 2023

Aug 14, 2023
BUY
$30.5 - $37.4 $815,875 - $1 Million
26,750 Added 195.76%
40,415 $1.42 Million
Q1 2023

May 12, 2023
SELL
$30.8 - $53.92 $114,822 - $201,013
-3,728 Reduced 21.43%
13,665 $446,000
Q4 2022

Feb 13, 2023
BUY
$45.4 - $60.91 $108,506 - $145,574
2,390 Added 15.93%
17,393 $958,000
Q3 2022

Nov 15, 2022
SELL
$42.06 - $55.45 $11,860 - $15,636
-282 Reduced 1.84%
15,003 $664,000
Q2 2022

Aug 15, 2022
SELL
$33.54 - $52.15 $335,265 - $521,291
-9,996 Reduced 39.54%
15,285 $745,000
Q1 2022

May 16, 2022
BUY
$33.14 - $51.13 $837,812 - $1.29 Million
25,281 New
25,281 $1.23 Million

Others Institutions Holding HRMY

# of Institutions
254
Shares Held
46.6M
Call Options Held
119K
Put Options Held
50K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.19B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email